Second Transplantation for Graft Failure
NCT03717545 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2020-09-24
Summary
Graft failure is a lethal complication after allogeneic stem cell transplantation, which often need a salvage transplantation. However, the current outcome of second transplantation for graft failure is far from satisfactory. We performed a prospective single-arm study to investigate the safety and efficacy of a novel regimen.
Conditions
- Graft Failure
- Stem Cell Transplant Complications
Interventions
- OTHER
-
second allogeneic stem cell transplantation
1. Change another donor 2. conditioning regimen: FLU/CY/anti-CD25 moAb
Sponsors & Collaborators
-
Peking University People's Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-01
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- China
Study Locations
More Related Trials
-
Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies
NCT02566395 ·Status: COMPLETED ·Phase: PHASE3
-
G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation
NCT01857336 ·Status: COMPLETED ·Phase: NA
-
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
NCT00253552 ·Status: TERMINATED ·Phase: NA
-
Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH
NCT01212796 ·Status: UNKNOWN
-
Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors
NCT05755854 ·Status: RECRUITING ·Phase: PHASE1
-
Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
NCT00569283 ·Status: COMPLETED ·Phase: PHASE1
-
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
NCT00378534 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplant for Bone Marrow Failure Syndromes
NCT00176878 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Randomized Trial of Mobilized Blood/Marrow Versus Blood Transplant
NCT01617473 ·Status: WITHDRAWN ·Phase: NA
-
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
NCT03870750 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00003396 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
NCT02161783 ·Status: RECRUITING
-
Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft
NCT03187756 ·Status: TERMINATED ·Phase: PHASE2
-
Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.
NCT02158767 ·Status: NO_LONGER_AVAILABLE
-
Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia
NCT00017654 ·Status: UNKNOWN ·Phase: NA
-
Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade
NCT06238245 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Bone Marrow Transplantation in Treating Patients With Leukemia
NCT00006451 ·Status: WITHDRAWN ·Phase: PHASE3
-
Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia
NCT03756675 ·Status: RECRUITING
-
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
NCT00533923 ·Status: COMPLETED ·Phase: PHASE2
-
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
NCT03272633 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer
NCT00627666 ·Status: COMPLETED ·Phase: PHASE2
-
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
NCT01904175 ·Status: COMPLETED
-
Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation
NCT03437603 ·Status: UNKNOWN ·Phase: PHASE2
-
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00005641 ·Status: TERMINATED ·Phase: PHASE2
-
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
NCT00295971 ·Status: COMPLETED ·Phase: PHASE1